Latest filing: Change in Management - Onesource Specialty Pharma Limited
ObservedCompany dossier
Onesource Specialty Pharma
NSE:ONESOURCE · ISIN INE013P01021
- Close
- ₹1,749.7 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Onesource Specialty Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹392.6 Cr · PAT ₹-68.8 Cr.
Exchange XBRLLatest ownership: promoter group 30.48% and public 69.52% as of 30 Jun 2026.
Exchange XBRLLatest rating action: OneSource Specialty Pharma Limited
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Change in Management - Onesource Specialty Pharma Limited
NSE · exchange filing
Observed
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Change in Management
BSE · exchange filing
Observed
Source filing Copy of Newspaper Publication - Onesource Specialty Pharma Limited
NSE · exchange filing
Observed
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · financial results
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹392.6 Cr
- Profit after tax
- ₹-68.8 Cr
- EPS
- ₹-6.31
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 30.48%
- Public
- 69.52%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL